The albumin levels at the beginning of the intervention within the values ​​considered as reference (3.5–4.8 d/dL) (Williamson and Synder, 2013); these findings are significant because, according to Ali et al. (Ali et al., 2021), hypoalbuminemia is seen in hospitalized COVID-19 patients, and this condition may persist after recovery and hospital discharge. The gene discussed is ALB; the disease is COVID-19.